Drug major Sun Pharmaceutical Industries today said it has launched Kapspargo Sprinkle (metoprolol succinate) extended-release capsules used for the treatment of hypertension, chest pain and heart failure in the US market.
Kapspargo Sprinkle pellets can be sprinkled over soft food or administered via a nasogastric tube, and are designed to facilitate long-term, once-daily administration, particularly for patients who have difficulty swallowing, Sun Pharma said in a BSE filing.
Sun Pharma North America CEO Abhay Gandhi said: "Kapspargo Sprinkle capsules may make it easier for patients to take their antihypertensive medication."
This innovative product is the latest example of Sun Pharma's use of advanced technology to create novel formulations of proven medications, he added.
Shares of Sun Pharmaceutical Industries today closed at Rs 575.60 per scrip on BSE, down 1.58 per cent from their previous close.
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)